The Efficacy and Safety of Programmed Death-1 and Programmed Death Ligand 1 Inhibitors for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis - He, S; Jiang, W; Fan, K (Front Oncol, 2021)
et al.